Novavax
NVAX
$4.09
Share price
3.54%
Change (1 day)
-45.90%
Change (1 year)
Categories
Novavax (NVAX) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.72 B
According to Novavax's latest financial reports the company has -$0.72 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Novavax - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-0.72 B | 13.07% |
| 2022-12-31 | $-0.64 B | 80.3% |
| 2021-12-31 | $-0.36 B | -156.07% |
| 2020-12-31 | $0.62 B | -437.18% |
| 2019-12-31 | $-0.19 B | 10.77% |
| 2018-12-31 | $-0.17 B | 65.08% |
| 2017-12-31 | $-0.11 B | 1734.33% |
| 2016-12-31 | $-5.55 M | -101.89% |
| 2015-12-31 | $0.29 B | 27.46% |
| 2014-12-31 | $0.22 B | 12.98% |
| 2013-12-31 | $0.20 B | 153.28% |
| 2012-12-31 | $80.24 M | 49.01% |
| 2011-12-31 | $53.84 M | -8.81% |
| 2010-12-31 | $59.05 M | -15.58% |
| 2009-12-31 | $69.95 M | 53.78% |
| 2008-12-31 | $45.48 M | -27.87% |
| 2007-12-31 | $63.06 M | -32.91% |
| 2006-12-31 | $94 M | 89.32% |
| 2005-12-31 | $49.65 M | 49.19% |
| 2004-12-31 | $33.28 M | -7.41% |
| 2003-12-31 | $35.94 M | 345.24% |
| 2002-12-31 | $8.07 M | -70.64% |
| 2001-12-31 | $27.49 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $39.75 B | -5,645.33% | 🇨🇭 Switzerland |
 Pfizer PFE | $89.28 B | -12,554.27% | 🇺🇸 USA |
 AstraZeneca AZN | $37.50 B | -5,330.80% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $16.28 B | -2,371.92% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $0.85 B | -219.86% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.42 B | -159.86% | 🇺🇸 USA |
 Agenus
AGEN | -$0.15 B | -79.30% | 🇺🇸 USA |
 NanoViricides NNVC | $12.45 M | -101.74% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -$0.46 B | -36.46% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.64 B | -190.57% | 🇺🇸 USA |